Skip to content

Drug interactions

Cannabidiol + Nateglinide

Severity: Minor

Cannabidiol and Nateglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cannabidiol may inhibit CYP2C9, the main enzyme metabolizing nateglinide. Nateglinide exposure could rise, increasing the risk of hypoglycemia.

What this interaction means in plain words

Cannabidiol and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Cannabidiol belongs to Central Nervous System; Nateglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP2C9-mediated metabolism of nateglinide.

What to do

Monitor blood glucose when cannabidiol is started or its dose changed. Reduce the nateglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cannabidiol with Nateglinide?

MediHelp rates the interaction as minor. Cannabidiol and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cannabidiol may inhibit CYP2C9, the main enzyme metabolizing nateglinide. Nateglinide exposure could rise, increasing the risk of hypoglycemia.

How serious is the interaction between Cannabidiol and Nateglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when cannabidiol is started or its dose changed. Reduce the nateglinide dose if hypoglycemia occurs.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in